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Abstract
Jama, Abdulrahman M. M.S. Department of Biochemistry and Molecular
Biology, Wright State University, 2018. Lipin1 regulates skeletal muscle
differentiation through the PKC/HDAC5/MEF2c:MyoD -mediated pathway
Our previous characterization of global lipin1-deficient (fld) mice demonstrated
that lipin1 played a novel role in skeletal muscle (SM) regeneration. The clinical
relevance of lipin1 has been observed in patients with lipin1 null mutations where they
exhibited severe rhabdomyolysis with aggregated and dysfunctional mitochondria. Lipin1
is a key gene that plays an important role in lipid biosynthesis and metabolism. It has
dual functions as it contains a phosphatase activity that converts phosphatidic acid (PA)
to diacylglycerol (DAG), the penultimate step in triglycerides (TAG) biosynthesis as well
as transcriptional co-activator function. In the cytosol and ER, lipin1 carries out its lipid
and phospholipid biosynthesis whereas in the nucleus it co-regulates the transcriptional
co-activation of genes involved in adipogenesis and fatty acid oxidation. In this study,
using cell-type specific Myf5-cre;Lipin1fl/fl conditional knockout mice (Lipin1Myf5cKO) we
showed that lipin1 is a major determinant of SM development, termed myogenesis.
Lipin1 deficiency induced reduced muscle mass. Results from lipin1-deficient myoblasts
suggested that lipin1 regulated myoblast differentiation through the protein kinase C
(PKC)/histone deacetylase 5 (HDAC5)/Myocyte-specific enhancer factor 2C
(MEF2c):MyoD-mediated pathway. Lipin1 deficiency leads to the suppression of PKC
isoform activities, as well as the inhibition of their downstream target, class II
deacetylase HDAC5 nuclear export, and consequently, the inhibition of MEF2c and
MyoD expression in the SM of Lipin1Myf5cKO mice. Inhibition of MyoD induced Pax7
accumulation, which may lead to an increased propensity for satellite cell self-renewal
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rather than progression through myogenic differentiation. Our findings provide insights
into the signaling circuitry that regulates SM development, and have important
implications for developing therapies aimed at treating rhabdomyolysis and muscular
dystrophies.
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I.

Introduction

i- Myogenesis
Muscles are thought to account for about 40% of the human body. There are three
types of muscles including smooth, cardiac and skeletal. Their primary functions are for
locomotion and contractile movements of internal organs such as the heart. Both smooth
and cardiac muscles differ from skeletal muscles as they function involuntarily and
rhythmically. Skeletal muscles on the other hand are anchored to the bones and are
primarily responsible for skeletal locomotion in maintaining physical activities and are
controlled voluntarily (Iizuka, Machida, & Hirafuji, 2014). During embryonic
development, somite cells give rise to mesenchyme stem cells, which in turn give rise to
muscle stem cells (Endo, 2015; Sambasivan & Tajbakhsh, 2015). The process of skeletal
muscles development also known as myogenesis follows a distinct pattern during
embryogenesis as well as postnatal in response to injury, termed, regeneration (Endo,
2015; Sambasivan & Tajbakhsh, 2015). The regeneration ability of skeletal muscles
through muscle stem cells, also known as satellite cells, gives them a unique role in
which a cascade of events drive these satellite cells to become mature myofibers and
eventually functioning skeletal muscles. Satellite cells exist in a low cycling; mitotically
quiescent stage that is ready for committing to myogenesis (Sambasivan & Tajbakhsh,
2015). In healthy muscle, satellite cells reside in a quiescent state where a pool of muscle
stem cells is available for muscle repair. Upon injury to muscles, satellite cells exit their
proliferative stage and commit to differentiation (Sambasivan & Tajbakhsh, 2015). The
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discovery of satellite cells, which were termed as muscle stem cells gave an insight to the
process of skeletal muscle development and regeneration. Satellite cells are the
precursors to skeletal muscle cells, and have their own unique molecular gene
expressions (Danoviz & Yablonka-Reuveni, 2012; Mauro, 1961). Some genes or markers
that are important for satellite cells identity include Pax3 and Pax7 as well as some
myogenic regulatory factors (Sincennes, Brun, & Rudnicki, 2016).
Myogenic regulatory factors (MRFs) are set of genes that are important for the
skeletal muscle formation. They govern the process of early muscle stem cells becoming
myoblasts to myofiber and subsequently, mature muscle fibers (Asfour, Allouh, & Said,
2018; Sambasivan & Tajbakhsh, 2015). MRFs include MyoD, Myf5, Myogenin, and
Mrf4. These factors contribute to different stages of muscle development and
regeneration (Asfour et al., 2018). MRFs are transcription factors and all have structural
similarities in their domains. One of the most important domains across all these factors
includes basic Helix-loop-Helix (bHLH) domain. This domain is thought to bind to a
specific DNA sequence known as E-box (Asfour et al., 2018; Molkentin, Black, Martin,
& Olson, 1995). E-box are ubiquitously found in the promoter of myogenic and nonmyogenic genes where they promote or enhance the transcription of these genes. One of
the earliest MRFs that is expressed is myf5; even as early as in mesoderm stage (Endo,
2015; Maguire, Isaacs, & Pownall, 2012). The expression of these MRFs follows a linear
pattern in each stage of myogenesis where Myf5 is expressed in the earliest muscle stem
cell commitment stage as well as Pax3 and Pax7 (W. Zhang, Behringer, & Olson, 1995).
The transcription factor MyoD comes at a later stage than Myf5 where it acts on
myoblasts differentiation (Asfour et al., 2018; Wood, Etemad, Yamamoto, & Goldhamer,
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2013). Myogenin and Mrf4 are expressed in the late stage of differentiation and matured
myofiber formation (Asfour et al., 2018; Wood et al., 2013).
Another family transcription factors that are involved in myogenesis are Myocyte
Enhancing Factor 2 family, MEF2s (Potthoff & Olson, 2007). MEF2 genes are expressed
in early mesoderm as well as later stage of myoblast differentiation (Bour et al., 1995).
There are many isoforms of MEF2 transcription factors and different isoforms have
shown to be uniquely expressed in different tissues. The MEF2 that is mostly present in
myogenesis is MEF2c isoform (Potthoff & Olson, 2007). This isoform does not have its
own myogenic activity and cannot by itself drive the cells to skeletal myogenic
differentiation. But with the cooperation of MyoD, they both drive and enhance the
myogenic differentiation process (Molkentin et al., 1995; D. Z. Wang, Valdez, McAnally,
Richardson, & Olson, 2001). MyoD along with other MRFs have unique sites where
MEF2 factors bind to enhance myogenesis, these sites are known as MEF2 binding sites,
which are located in the promoter regions and close to the E-box sites (Naidu, Ludolph,
To, Hinterberger, & Konieczny, 1995).
Next is how and what negatively regulates these factors and myogenesis overall.
The intrinsic biological course is to up-regulate sets of genes and processes and to downregulate them at another time point, when they are not needed. In this case, as
aforementioned, the myogenesis process takes place during embryogenesis and in
response to injury. When myogenesis is not needed these MRFs and MEFs must be
down-regulated (D. Z. Wang et al., 2001). Repressor genes are regulatory factors that
down-regulate the expression of genes by binding to a short specific DNA sequence in
the promoter regions of other genes (Reynolds, O'Shaughnessy, & Hendrich, 2013). One
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of the many ways that DNA transcription is regulated is the process of chromatin
remodeling. When DNA is transcribed, it is packaged into histone proteins where they
form nucleosomes (Tessarz & Kouzarides, 2014). This makes the cells store all DNA
materials as well as control the expression of certain genes. Histone proteins are repressor
proteins, which makes the DNA transcriptional complex machinery unable to access the
DNA (Bertos, Wang, & Yang, 2001). The histone proteins or chromatins are remodeled
based on the need of the cells (Reynolds et al., 2013). Some of the histone remodeling
include, methylation, acetylation, phosphorylation, ubiquitylation and sumoylation
(Tessarz & Kouzarides, 2014). When histones are methylated, it is considered to be gene
repression while acetylation is considered to be gene transcriptional activation as it frees
the DNA from the histone proteins, thus making the DNA transcription complex
accessible to the DNA for transcription (Bertos et al., 2001; Reynolds et al., 2013;
Sincennes et al., 2016).
Histone modification and remodeling plays an important role in gene regulations
in myogenesis (Lu, McKinsey, Zhang, & Olson, 2000; McKinsey, Zhang, Lu, & Olson,
2000). It has been evidenced that Histone Deacetylases (HDACs) play an important role
in gene transcription. These proteins are shown to inhibit gene transcription by removing
acetyl groups from histones, thus making transcription unachievable (Bertos et al., 2001;
Sincennes et al., 2016; Tessarz & Kouzarides, 2014). HDACs fall into various classes
with distinct tissue expression (Dokmanovic, Clarke, & Marks, 2007). Class I HDACs
are ubiquitously expressed as compared to class II (Fischle et al., 1999). One of the
tissue-specific expressions of class II HDACs are in skeletal muscle, which plays an
important role in myogenesis during embryogenesis and regeneration (McKinsey, Zhang,
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Lu, et al., 2000; Sincennes et al., 2016). Through the CaMK (Ca2+/calmodulin-dependent
protein kinase) and Protein Kinase D (PKD) signaling pathway, HDAC5, a class II
protein binds to 14-3-3 binding protein which are cellular signaling chaperones
(McKinsey, Zhang, & Olson, 2000). The binding between HDAC5 and 14-3-3 chaperone
proteins is aided by the phosphorylation signal of PKD and CaMK. In a repression
scenario, HDAC5 and MEF2c interact, which reduces and diminishes the myogenic
differentiation process. This makes HDAC5 reside mostly in the nucleus and carryout its
repression activity. Upon PKD and CaMK signaling activation, HDAC5 is exported from
the nucleus through phosphorylation manner with the aid of 14-3-3 binding protein (Lu,
McKinsey, Nicol, & Olson, 2000; McKinsey, Zhang, Lu, et al., 2000; McKinsey, Zhang,
& Olson, 2000).

ii- Rhabdomyolysis/Myoglobinuria
Rhabdomyolysis, often a genetic disorder, is the results of muscle fiber
breakdown that leads to toxic release of cellular components into the circulatory system
(Zutt, van der Kooi, Linthorst, Wanders, & de Visser, 2014). In the United States alone, it
has been reported about 26,000 cases annually (Sauret, Marinides, & Wang, 2002; Zutt et
al., 2014). One of the characteristic of rhabdomyolysis is the elevation of serum creatine
kinase activity. There are two classes of rhabdomyolysis: acute and severe episodes
(Veenstra, Smit, Krediet, & Arisz, 1994). Severe muscular dystrophy phenotypes as well
as myoglobinuria, the excessive presence of myoglobin in urine, are often accompanied
in patients with severe rhabdomyolysis (Sauret et al., 2002; Veenstra et al., 1994; Zutt et
al., 2014). One of the pathology observed in some patients with rhabdomyolysis is an
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increased intercellular concentration of calcium. This excess presence of calcium is
thought to lead to the activation of cellular proteases and phosphatases, which in turn
destruct and teardown myofibers and cytoskeletal membrane proteins (Sauret et al., 2002;
Veenstra et al., 1994; Zutt et al., 2014). The cause of rhabdomyolysis cannot be pinned
down to one specific underlying genetic disorder although many causes have been
identified. Acquired rhabdomyolysis cases are the results of substance abuses (alcohol
etc.) accompanied by another causative factor such as lack of exercise or sedentary
lifestyle (Sauret et al., 2002; Veenstra et al., 1994), whereas some of inherited cases are
attributed to the dysfunction of the terminal glycolysis/gluconeogenesis pathways and
lipid metabolism (Zutt et al., 2014; Zutt et al., 2010).

iii- Lipin proteins
Lipid metabolism is a dynamic process that is important for cellular energy
storage, cellular integrity and membrane maintenance. Proteins involved in lipid
metabolism play an important role in lipid synthesis and their cellular trafficking (Brose,
Betz, & Wegmeyer, 2004; Y. Chen, Rui, Tang, & Hu, 2015). Some of the proteins that
are associated in lipid metabolism include the lipin family proteins. This family of
proteins consists of three different proteins, lipin1, lipin2 and lipin3 that are expressed in
tissue specific and sometimes in an overlapping manner (Figure 1) (Y. Chen et al., 2015;
Csaki et al., 2013; Donkor, Sariahmetoglu, Dewald, Brindley, & Reue, 2007). The
members of this family have a phosphatidate acid phosphatase (PAP) enzyme activity
that catalyzes the conversion or the dephosphorylation of phosphatidic acid (PA) to
diacylglycerol (DAG), the penultimate step in synthesis of triglycerides (TAG). In
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addition to taking part of energy storage, TAG synthesis, lipin proteins are also involved
in fatty acid oxidation through their secondary function. They co-regulate the gene
expression of fatty acid oxidation genes (Y. Chen et al., 2015; Csaki et al., 2013; Ren et
al., 2010). Structurally, (Figure 2), all lipin family proteins consist of an evolutionarily
conserved C-terminal (C-Lip) and N-terminal (N-Lip) domains as well as nuclear
localization signal (NLS) (Y. Chen et al., 2015). The Haloacid dehalogenase (HAD)
phosphatase motive (DXDXT) is the PAP enzyme and is located in the C-Lip domain as
well as the nuclear receptor interacting domain (LXXIL) (Y. Chen et al., 2015; Csaki et
al., 2013). Due to its dual activity, lipin1 is trafficked between cellular compartments
where it carries its PAP activity in the cytoplasm/ER and the transcription co-regulation
in the nucleus (Y. Chen et al., 2015; Harris et al., 2007). Peterson et al (2011) proposed
that mTOR1 complex regulates the translocation of lipin1 from the cytoplasm to the
nucleus (Peterson et al., 2011). They have shown that when lipin1 is phosphorylated by
mTOR1, lipin1 is sequestered in the cytoplasm, where it carries out its PAP activity. On
the other hand, when lipin1 is not phosphorylated, it travels to the nucleus where it acts as
transcriptional co-activator in genes involved in the fatty acid oxidation pathway as well
as adipogenesis (Kim et al., 2013; Peterson et al., 2011).
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Figure 1: Relative mRNA expression of lipin proteins in different mouse tissue. Lipin1
is predominantly expressed in adipose tissue and skeletal muscles (Csaki et al., 2013).

The lipin family proteins were first identified in a spontaneous mutant mouse
strain, which later named fatty liver dystrophy mouse (fld). These mice displayed a
dysregulated TAG storage (Csaki et al., 2013; Peterfy, Phan, Xu, & Reue, 2001; H.
Wang, Airola, & Reue, 2017). Through positional cloning, (Peterfy et al., 2001) lipin1
was identified in mice. From to the null mutation of lipin1 they have characterized these
mice to exhibit lipodystrophy, hyper-triglyceridemia, neonatal fatty liver, insulin
resistance and peripheral neuropathy (Y. Chen et al., 2015). Lipin1 mutations in humans
present similar phenotype as that of mice as they both exhibit smaller and atrophied
muscles (Y. Chen et al., 2015; Jiang et al., 2015; Michot et al., 2012). A study carried out
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by Michot et al., (2012) has shown that human patients with lipin1 mutations presented
severe episodes of rhabdomyolysis. In addition to severe rhabdomyolysis, they also
observed lipid droplet accumulation from muscle biopsies (Y. Chen et al., 2015; Michot
et al., 2012). When it comes to human patients with lipin1 mutations, the phenotype
differs from that of fld mice. Human patients do not show lipodystrophy but present
severe muscle damage in early childhood (Y. Chen et al., 2015; Sauret et al., 2002).

Figure 2: Lipin1 protein domains(Y. Chen et al., 2015). (NLS = Nuclear Localization
Signal. DxDxT = Catalytic motif. LxxIL = Transcription co-activator motif.)

iv- Lipin1 enzymatic activity
PAP activity of lipin1 is important for its contributive role in phospholipid and
TAG metabolism (Ren et al., 2010). TAG is an important molecule in energy storage as
well as energy homeostasis. The path to TAG formation is primarily through the
Kennedy Pathway, where a sequential acylation of glycerol phosphate takes place (Y.
Chen et al., 2015). PA is a precursor for DAG and TAG and therefore dephosphorylated
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by lipin proteins through their PAP enzymatic activity, a magnesium dependent (Mg2+)
catalytic activity. This means that lipin proteins are specific for PA and not other PA
species like lipid phosphate phosphatase, which do not require Mg2+ (Y. Chen et al.,
2015). Lipin1 is the predominant isoform of lipins, and account for almost all of the PAP
activity in skeletal muscle and adipose tissue. This was evidenced in fld mice (Y. Chen et
al., 2015; Donkor et al., 2007).

v- Lipin1 transcription co-activation activity
Lipin proteins and their lipid metabolism activity lie in their dual function activity
(Figure 3). The enzymatic activity of these proteins contribute to the TAG and
phospholipid accumulation the cellular system requires (Y. Chen et al., 2015). Their
secondary activity is the transcriptional co-activation of proteins involved in fatty acid
oxidation as well as genes that are involved in adipocyte differentiation (Y. Chen et al.,
2015). Lipin1 co-activates key genes in adipogenesis by interacting with Peroxisome
Proliferator –Activated Receptor gamma (PPARγ), which is a master regulator in
adipocyte differentiation (Kim et al., 2013). In adipogenesis, lipin1 was found to
positively regulate adipocyte maturation and differentiation by interacting, through its
Transcripional Activating Domain (TAD), with PPARγ and this interaction has shown to
enhance PPARγ activity (Kim et al., 2013). The TAD domain, located at the N-terminal
of lipin1, only interacts with PPARγ and not Peroxisome Proliferator-Activating
Receptor α (PPARα), which allows the transcriptional co-activation of adipogenesis,
seperate from co-activation of genes involved in fatty acid oxidation. The transcription
co-activation mechanism of lipin1 protein contributes to TAG and phospholipid build-ups
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through maintenance and differentiation, and on the other hand regulating genes that
break down fatty acids. Studies using PPARα and PPAR-coactivator-1α (PGC-1α)
knockout mice have shown that lipin1 forms a complex with them to activate fatty acid
oxidation (Y. Chen et al., 2015; Ren et al., 2010). It is suggested that the neonatal fld
phenotype is due to the loss of the the co-activator function of lipin1 and inhibition of
fatty acid oxidation (Y. Chen et al., 2015; Finck et al., 2006). Although lipin1 is
predominately expressed in adipose tissue and skeletal muscle in adult mice, lipin2
predominates the liver and have been shown to be elevated in fld mice. This elevation of
lipin2 is considered to be a compensatory effect of lipin1 deficiency and this contributes
to the hypertriglycemia phenotype in fld mice (Finck et al., 2006).

Figure 3: Lipin proteins and their dual function in ER for enzymatic activity,
converting PA to DAG and Nucleus for transcriptional co-activation of fatty acid
oxidation genes (Y. Chen et al., 2015).
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vi- Phospholipids and secondary signaling
One of the main features of lipin1 is its contribution to TAG accumulation
through dephosphorylation of PA to DAG and eventually TAG synthesis (Qi, Sun, &
Yang, 2017). DAG is an important molecule as a precursor for TAG synthesis as well as
a lipid secondary signaling molecule (Figure 4). The secondary signaling activity of DAG
plays a central role in a variety of biological signaling pathways (Newton, 2001; Q. J.
Wang, 2006). DAG is mostly anchored to the plasma membrane where it carries both
activities of TAG synthesis and secondary signaling activity that leads to the recruitment
of Protein Kinase C (PKC) (Eichmann & Lass, 2015). PKC consists of many isoforms
and some of them interact with DAG and tumor-promoting phorbol esters, DAG analogs,
which leads to their activation (Newton, 2001). One of the characteristics those isoforms
have is the presence of C1 domain, a cysteine rich domain (Newton, 2001). This domain
is important for the interaction between DAG and PKCs. When PKCs get activated and
sequestered to the plasma membrane from the cytoplasm, they are phosphorylated,
leading to downstream activation of other kinases that are required for cellular
differentiation and cell growth (Eichmann & Lass, 2015; Newton, 2001; Q. J. Wang,
2006). As stated, PKC consists of a variety of isoforms or isozsymes. They are put into
four different classes: Conventional (α, γ, βΙ & βΙΙ), novel (δ, ε, η, & θ) and atypical (ξ &
ι/λ) as well as PKCµ and υ. The latter isoforms are sometime classified as their own
group of protein kinases called Protein Kinase D or PKD (Newton, 2001). Conventional
and novel isoforms are activated by DAG as they contain C1 domains (Q. J. Wang,
2006).
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Figure 4: Glycerol phosphate pathway for glycerolipid synthesis

vii- Lipin1 in skeletal muscles
As aforementioned, lipin1 expression is the highest in the skeletal muscles
compared to other lipin family proteins and all PAP activity in skeletal muscles is
through lipin1 (Donkor et al., 2007; Jiang et al., 2015; Michot et al., 2012). Patients with
lipin1 mutations that result missense, nonsense and frame shift show severe phenotype of
rhabdomyolysis and myoglobinuria. The underlying molecular mechanisms of what
contributes this pathology to these mutations are not clearly understood. In a study done
by Jiang et al (Jiang et al., 2015) in fld mice has shown that lipin1 is important for
skeletal muscle differentiation. They used barium chloride to induce muscle injury and
monitored the muscle regeneration process in fld and WT mice. Upon injury to muscles,
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they have shown that these mice had impaired skeletal muscle regeneration compared to
WT mice. They have concluded that lipin1 is important for skeletal muscle regeneration
(Jiang et al., 2015).

viii-

Hypothesis and Aims

Recent human studies have suggested that children with homozygous null
mutations in the LPIN1 gene suffer from rhabdomyolysis. Despite the well-known roles
of lipin1 in lipid biosynthesis and transcriptional regulation, the pathogenic mechanisms
leading to rhabdomyolysis remains unknown.
Through the work of Jiang et al (Jiang et al., 2015), it is established that lipin1 is
an important gene for skeletal muscle regeneration upon injury in fld mice. These mice
are lipin1 global knockout, meaning the mice are completely lipin1 deficient in every
tissue. Systemic factors due to global lipin1 deficiency may also contribute to skeletal
muscle phenotype of fld mice. Therefore, we hypothesize that lipin1 regulates skeletal
muscle during development. With that we came with three aims: 1) Generating mice with
lipin1 conditional knockout in myf5 expressing progenitor cell. Myf5 gene, as mentioned
earlier, is part of the myogenic regulatory factors and the earliest MRFs to be expressed
(Bentzinger, Wang, & Rudnicki, 2012; Endo, 2015; Wood et al., 2013). In this study, we
used this unique mouse model to explore the role of lipin1 in skeletal muscle to provide
new pathophysiologic insights into the role of lipin1 in rhabdomyolysis. 2) Determine the
role of lipin1 in skeletal muscle differentiation using myoblasts. 3) Identify the impact of
lipin1 deficiency on muscle satellite cells.
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II.

Materials and Methods

i- Generating Lipin1Myf5cKO mice and Genotyping
To generating Lipin1Myf5cKO,, lipin1flox/flox mice (Nadra et al., 2008) were crossed
with myf5-Cre mice that were purchased from Jackson laboratory (Stock No: 007893).
Homozygous lipin1 deficiency in skeletal muscle and their lipin1-positive littermates
(wild-type, WT) were used for this study. For genotyping, mice tails from newborns were
collected. In ice, 120µl of EDTA solution (pH 8.0) and 500µl of Nuclei Lysis Solution
were combined. 600µl of EDTA + Nuclei solution were added per tail followed by 8µl of
20mg/ml Proteinase K. The mixture and tail were incubated at 55˚C water bath overnight.
3µl of RNase were then added to the digested tails followed by inverting and incubating
15-30 minutes at 37˚C. In a room temperature, 200µl of Protein Precipitation Solution
were then added followed by a vigorous vortexing at high speed for 20 seconds. The
samples were then chilled on ice for 5 minutes. After ice incubation, the samples were
centrifuged for 4 minutes at 13,000-16,000 x g to precipitate proteins. The supernatant
containing the DNA were carefully removed and transferred to a clean 1.5ml
microcentrifuge. 600µl of Isopropanol were then added to precipitate the DNA followed
by 5 minutes of centrifugation at 13,000-16,000 x g at room temperature. 70% ethanol
was then used to wash DNA for several times and centrifuged for 1 minute at 13,00016,000 g at room temperature. Carefully, the ethanol was aspirated. The DNA pellet was
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then rehydrated with 50µl of dH2O. DNA was stored at 4˚C for short periods or at 80˚C if
not needed right away.
Two PCR programs were used to identify the correct transgenic mice. One PCR program
was to identify the presence of positive Cre+ allele. The other PCR program was to
identify the flox/flox allele or lipin1 mutation. In both programs, DreamTaq DNA
polymerase (Thermo fisher cat#: EP0702) was used. After the PCR reaction, DNA was
separated 1% Agarose (Alfa Aesar Cat#: J66369) gel electrophoresis. The PCR primers
used to detect Cre+ transgenic mice were one forward primer and two reverse primers.
One reverse primer was to detect the wild-type allele and the other one for the mutant
allele. The primers are: Forward 5’-CGTAGACGCCTGAAGAAGGTCAACCA-3’,
reverse primers: 5’-CACATTAGAAAACCTGCCAACACC-3’ and 5’ACGAAGTTATTAGGTCCCTCGAC-3’. For the flox/flox allele to detect the lipin1
mutant mice, the primers used are: Forward 5’ATAAGCGGCCGCCTGAGCACGTTCACACATAC-3’ and reverse, 5’GTCGTCGACCTCTTCTCACACTCTGCCCA-3’.

ii- Tissue Collection and Cutting
Once genotyping was completed, transgenic mice aged 8 to 20 weeks were
euthanized and the skeletal muscles, Gastrocnemius (GAS) and Tibialis Anterior (TA),
were collected. Tissue for Immunohistochemistry and H&E staining were applied with
Optimal Cutting Temperature (OCT) and quickly frozen by dipping in an Isopentane (160˚C) for 10 seconds. The tissues were then stored at -80˚C freezer. For the H&E
staining, the muscle tissue were cut into thin section about 7-15 microns using Thermo
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Fisher cryostat micron HM550 at a temperature set -20˚C. For muscle tissues designated
for western blotting and RNA, they were quickly frozen using liquid nitrogen.

iii- Cell culture and C2C12 myoblasts Differentiation
Mouse C2C12 myoblast cells were cultured cultured in high-glucose Dulbecco's
modified Eagle's medium (Gibco) and was supplemented with 10% (v/v) fetal bovine
serum (Gibco) and 1% penicillin-streptomycin (P/S) (Invitrogen) under humidified air
containing 5% CO2 at 37 °C. The cells were split and passaged every two days to avoid
100% confluency. For differentiation, C2C12 cells were passaged into 6 well plates with
full media. Next day, top three well cells were transfected with 0.4µl of shLpin1
adenovirus and 12µl of 8mg/ml polybrene. The bottom, the control, were transfected with
either shLacz or no virus at all. Following day, the media was changed and let the cells
recover from transfection. Monitering for 100% confluency in the next day or so, Day
zero (DT0) were harvested. The remaing cells were then given differentiation media by
replacing growth medium with differentiation medium consisting of Dulbecco's modified
Eagle's medium supplemented with 2% horse medium (Gibco) and 1% penicillinstreptomycin (invitrogen). The cells were given fresh media every two days. Day 4 (DT4)
and Day 6 (DT6) were subsequently harvested. The differentiated myotubes were then
analyzed using western blot or mRNA analysis.

iv- Immunofluorescence
C2C12 cells were plated in a 6 well plate and were differentiated. At day 6, the
media was removed from the cells and washed with 3X 1xPBS. Cells were then fixed
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using 4% paraformaldehyde made with PBS for 20 minutes at room temperature. The
residual paraformaldehyde (32% solution EMS cat#: 15714-s lot# 121010) was removed
by washing the monolayer 2X with 1xPBS. The cells were then permeabilized by
incubating them with 0.1% Triton X-100 made in PBS for 15 minutes at room
temperature. 3x wash with 1xPBS followed. Cells were then blocked using 1% BSA
(Thermo fisher lot: 155423) made with PBS for 1 hour at room temperature. The cells
were then incubated with the Mf20 monoclonal antibody (DSHB) to detect MHCexpressing cells overnight at 4°C and subsequently with an Alexa Fluor 488- or Alexa
Fluor 555-conjugated secondary antibody (Invitrogen) for 1 h at room temperature. Next,
cells were incubated with DAPI for 10 minutes followed by 3x with PBS, 5 minutes each.
The plates were then let dry and images were taken using an inverted microscope
Olympus IX70 equipped with a Leica DFC7000T camera.

v- DNA transfection and Immunofluorescence
In a 6 well plate, COS7 cells were seeded onto glass coverslips. Upon 80-90%
confluency, cells were transfected with GFP-tagged HDAC5 (Addgene # 32211)
with/without HA-tagged lipin1, HA-tagged Lipin D712A mutant or HA-tagged PKCu
(Addgene #10808) plasmids using transfection reagent polyethylenimine (PEI). 6 hours
post transfection; the media was the replenished with fresh full media
(DMEM+10%FBS+1%P/S). After 24 hours post transfection, the media was removed
and cells were fixed using 4% paraformaldehyde for 15 minutes at room temperature.
Fixation was followed by washes, 2x washes with PBS, and then permeabilization with
0.1% Triton X-100. After washes, the cells were blocked with 1% BSA (Thermo Fisher)
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in PBS for 1 hour. The cells were then incubated with Rabbit anti HA primary antibody
(1:1000) in 1% BSA in PBS overnight at 4˚C. The cells were then subsequently
incubated with secondary antibody, Alexa Flour Goat anti-Rabbit 555 with 1% BSA
blocking reagent. Cells were then labeled with DAPI for nuclei staining. Co-localization
of HDAC5 and Lipin1, Lipin1D712A or PKCu was examined using inverted microscope
Olympus IX70 equipped with a Leica DFC7000T camera.

vi- Immunohistochemistry
GAS and TA muscles from both wild type and Lipin1Myf5cKO were cryosectionedusing cryostat that was cut into 7-15µ. The cryosections biopsies on microscope slides
(Thermo fisher Cat#: 22-230-900) were then let air dried for 1 hour at room temperature.
The sections were then fixed with 4% paraformaldehyde, followed by 3x 3 minutes
washes. Heat activated antigen retrieval was performed by placing the slides in 10mM
citrate buffer (pH 6.5) and then put the coplin jar in boiling water at 92˚C for 20 minutes
using pressure cooker. The slides were then let cool at room temperature for 1 hour with
the citrate buffer. Liquid blocker was then used to draw the section boundaries.
Endogenous peroxidases were then blocked with 3% H2O2 for 7 minutes at room
temperature following 3x 3 minute washes. The slides were then washed 3x 3 minutes.
Sections were then blocked using M.O.M (Vectorlabs MKB-2213) in PBS for 1 hour at
room temperature, followed by another blocking with 1% blocking reagent (Invitrogen
TSA kit lot: 1856764) for another 1 hour at room temperature. Pax7 (DSHB) and Rabbit
laminin (Abcam11575) primary antibodies in 1% blocking reagent were incubated
overnight at 4˚C, 1:5 and 1:200, respectively. Next day, the sections were washed with
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PBS 3x 5 minute at room temperature, followed by incubating with secondary Goat anti
mouse Biotinylated (Jackson Immune research cat#: 115-065-205) in 1% blocking
reagent (1:1000) at room temperature. After 3x 5 minute washes, the sections were
incubated with SA-HRP (Invitrogen TSA kit) in PBS for 1 hour at room temperature.
Sections were then incubated with Alexa flour 488 (1:200) (Invitrogen) and Goat antiRabbit 555 (1:250) in amplification diluent (Invitrogen) for 1 hour at room temperature.
After another set of washes, sections were incubated with DAPI (1:2000) in PBS for 10
minutes at room temperature. The sections/slides were then let dry and mounted with
Vectasheild Mounting media (Vector labs, H-1000). Slides were then viewed using
inverted microscope Olympus IX70 equipped with a Leica DFC7000T camera.

vii- RNA extraction and Quantitative real-time PCR
For C2C12 cells and muscle tissue RNA extraction, 1ml of Trizol reagent
(Invitrogen) was used. After cells/tissue were lysed with Trizol, 200µl of chloroform was
added and vigorously shaken for 15 seconds. Samples were then incubated for 2-3
minutes at room temperature followed by centrifugation 12,000 g for 15 minutes at 4˚C.
The colorless upper aqueous phase was carefully taken to a new tube and mixed with
500µl of isopropanol. Samples were then incubated at room temperature for 10 minutes
with rocking followed by centrifugation at 12,000 g for 10 minutes at 4˚C. The
supernatant was then carefully removed. The pellet was then washed with 70% ethanol to
remove the residual isopropanol and was centrifuged at 7,500 g for 10 minutes at 4˚C.
The ethanol was then carefully removed by pipetting. The pellet was then resuspended
with RNase-free water. RNA quality and concentration was measured by using
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NanoDrop 2000 (Thermo Fisher Scientific). For cDNA synthesis, 1µg of total RNA was
used for reverse transcription with the High-Capacity cDNA Reverse Transcription Kit
(Thermo Fisher Scientific). Quantitative real-time PCR (qPCR) reaction was performed
in a QuantStudio Real-Time PCR System (Thermo Fisher Scientific) system using
SYBR®Green Real-time PCR Master Mix (Bio-Rad). For qPCR analysis, The Ct (2-ΔΔCt)
method was used. For list of primers used, see Table 1.
Primer

Forward 5'---->3'

Reverse 5'---->3'

Lipin-1

CCTTCTATGCTGCTTTTGGGAACC

GTGATCGACCACTTCGCAGAGC

Myf5

TGTATCCCCTCACCAGAGGAT

GGCTGTAATAGTTCTCCACCTGTT

MyoD

GCAGGCTCTGCTGCGCGACC

TGCAGTCGATCTCTCAAAGCACC

MEF2c

TCTGTCTGGCTTCAACACTG

TGGTGGTACGGTCTCTAGGA

Gapdh

CCAATGTGTCCGTCGTGGATCT

GTTGAAGTCGCAGGAGACAACC

Table 1: Primer sequences used for qPCR 1

viii-

MicroRNA analysis

Total RNA was isolated from GAS muscle of LipinMyf5cKO and control mice using
TRIzol reagent (Invitrogen). For miRNA RT-PCR, cDNA from 200 ng of total RNA was
synthesized using Taqman microRNA reverse transcription kit (Applied Biosystems).
Real time PCR of Hsa-miR-1 (Applied Biosystems) was carried out with Taqman
Universal master mix II following the manufacturer's instructions (Applied Biosystems).
U6 SnRNA (Applied Biosystems) was used as an internal control for microRNA
analysis.
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ix- Western blotting
For protein expression analysis, muscle tissues were homogenized with cocktail
containing RIPA buffer (20-188 EMD Millipore Sigma), 0.2% Protease Inhibitors
(SIGMA Complete™ Protease Inhibitor Cocktail 04693116001) and 0.2% Phosphatases
inhibitors (SIGMA P2850 - Phosphatase Inhibitor Cocktail 1). Once lysed with
homogenizer, samples were centrifuged at 12,000 rpm for 10 minutes. The supernatant
was collected and aliquoted in new 1.5ml microcentrifuge tubes. Bicinchoninic
acid assay (BCA) was carried out for protein concentration analysis for each sample.
About 2mg/ml of BSA was used as standards (0 for blank, 1µl, 2µl, 3µl, 4µl, 5µl and
6µl) and loaded in 96 well plates. 1-3µl of samples was then loaded. Each standards and
samples were duplicated. Plates were then incubated at 37˚C for 20-30 minutes followed
by protein absorbance measurement using SynergyH1 microplate reader with a
wavelength at 567. The standard curve was used to calculate the sample concentrations
and water was water was added to adjust the volumes.
Acrylamide gel (30% acrylamide Solution 37.5:1 BioRad Cat. 1610158) was used
to separate proteins using gels (7.5%-15% gels). Samples were prepared for running after
the desired amount of protein for running was calculated (20µg-60µg). After readjusting
with dH2O, 4x-loading dye was added to each sample. Samples were then heated in
boiling (95˚C) for 5 minutes followed by spin down. Afterwards, the samples and protein
ladders (Fisher Cat#: 26616) (BioRad Cat#: 161-0373) were loaded into the SDS gel in
running buffer with the voltage set to 100v and increasing it to 120v once it goes through
the stacking gel. For transferring, PVDF membranes were soaked into methanol for 1-3
minutes and then into a transfer buffer. Sponges, soaked in transfer buffer were then
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placed on the black place followed by filter paper also soaked in transfer buffer. The SDS
gels, after the running was completed, were removed from the plates. Gels were then
placed on the filter paper and the sponged followed by the PVDF membrane. Using a
glass pipette, the bubbles were carefully removed. Another set of filter paper and a
sponge soaked transfer buffer was placed. The transfer system was set up so that the
black plate of the sandwich is close to the black side of the system. The system was then
filled with transfer buffer. To avoid an increase in in temperature during the transfer, the
system was place an ice container surrounding it. The proteins were transferred to the
membrane at 0.30A for 2 hours. After transfer, membranes were blocked using 1% casein
buffer for 1 hour at room temperature. Afterwards, the membranes were incubated with
primary antibodies made with 1% casein buffer overnight at 4˚C with rocking. Next day,
memberanes were washed with TBST (1x TBS buffer + 0.1% Tween20, Fisher Cat#:
175476) and incubated with secondary antibodies for 1 hour at room tempereture with
rocking. The scondary antibodies were diluted in 1.0% casein + 0.1 % Tween 20 + 0.1%
10% SDS buffer. The blots were visualized using Chemiluminescense kit from Pierce™
ECL Western Blotting Substrate (catalog # 32106). The instrument used for the
visualization is Amersham Imager 600 (GE life sciences). Antibodies that were used
include lipin1 (Cell signaling Technology, Cat#: 14906, phospho-PKCµ 744/748 (Cell
signaling Technology, Cat#: 2054,), MyoD (Abcam Cat#: 16148), MEF2c (Cell signaling
Technology Cat #: 5030) phospho-PKCα (Santa Cruz Biotechnology cat#: sc-377565),
phospho-PKCθ (Santa Cruz Biotechnology cat#: 271922) and Pax7 (DHSB and Abcam
cat#: 34360), along with goat anti-mouse IgG-HRP and goat anti-rabbit IgG-HRP
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seondary antibodies (Promega, USA). For loading control primary antibodies, GAPDH
(Abcam cat#: 181602) and Beta-actin (Sigma cat#: 1978).

Statistical analysis. In each graph, unless noted otherwise, data represent mean ± SD of
(n)-number of independent experiments. Statistical significance was calculated by a twotailed Student t-test. P values < 0.05 were considered statistically significant.
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III.

Data and Results

1. Lipin1 knockout in Myf5-expressing precursors leads to suppression of
skeletal muscle development.
The aim of generating mice that lack lipin1 in skeletal muscle progenitor
precursors was to investigate the role of lipin1 in skeletal muscles development. The loss
of lipin1 in skeletal muscles did not cause severe ectopic phenotypes although an altered
fat deposition was observed (Figure 5A). Some phenotypes that are observed in fld mice
such as hind-limb clasping reflexes, tremors, or an unsteady gait were absent from these
conditional knockout Lipin1Myf5cKO mice. On the other hand when lipin1 was knocked out
in the skeletal muscle progenitors, the muscles of these mice were developmentally
suppressed. About 24% muscle mass reduction was observed in both Tibialis anterior
(TA) and gastrocnemius (GAS) of Lipin1Myf5cKO mice (Fig 5A-C) compared to their wild
type cohorts.
Next we measured the protein expression of key genes that are important for
myogenesis in Lipin1Myf5cKO mice. First, we measured the lipin1 protein expression and
found that it has been completely abolished in both the TA and GAS muscles as expected
(Figure 6A). Once we established that lipin1 expression is depleted in these muscles with
observed phenotype, in muscle mass change, we sought to further investigate key
markers for myogenesis. Myf5, MyoD and MEF2c protein expression were analyzed.
The expression levels of Myf5 were not changed in both TA and GAS even though lipin1
was depleted in Myf5 expressing progenitors. On the other hand, MyoD and MEF2c their
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expression were reduced by 48% and 60%, respectively (Figure 6B). This change in
MyoD and MEF2c and no change in Myf5 protein levels further illustrates that Myf5 is
expressed earlier than both MyoD and MEF2c and that lipin1 deficiency had no impact
on Myf5 protein expression. In addition to measuring protein expression, we also
analyzed the mRNA levels of these genes. Lipin1 was reduced in the mRNA level as well
as MyoD and MEF2c. But there was no change in Myf5 mRNA levels, consistent with
the protein expression levels (Figure 6C).
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Figure 5: Lipin1 deficiency in Myf5-expressing cells results in reduced skeletal muscle
mass. (A) Appearance of Tibialis anterior (TA) and gastrocnemius (GAS) muscles in WT
and Lipin1Myf5cKO mice at 3-month-old of age (TA and GAS were indicated by arrows).
Isolated TA and GAS muscle (B) and the muscle weight (C) in WT and Lipin1Myf5cKO
mice. (WT vs. Lipin1Myf5cKO, *p<0.05; **p<0.01 Student’s t-test).
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Figure 6: Lipin1 depletion in Myf5-expressing progenitor cells inhibit MEF2 and
MyoD expression, but did not alter Myf5 expression. Western blot (A), the densitometry
graphs (B), and mRNA expression (C) of lipin1, myogenic regulatory factors (Myf5 and
MyoD) and of myogenic enhancer factor (MEF2c) in GAS and TA muscles of 3-monthold WT and Lipin1Myf5cKO mice. Unless otherwise indicated, data are from one
representative (n = 3) of at least three independent experiments. (*p<0.05; **p<0.01
Student’s t-test).
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2. Lipin1 deficiency leads to reduction in PKC activation.
Phosphatidic acid phosphatase (PAP) activity of lipin1 is important for converting
phosphatidic acid (PA) to diacylglycerol (DAG). This makes lipin1 an important
molecule for DAG synthesis (Newton, 2001; Q. J. Wang, 2006). Studies have shown that
lipin1 overexpression leads to an increase in cellular DAG contents while a depletion of
lipin1 leads to the reduction in DAG accumulation (Ren et al., 2010). DAG is an
important molecule in both Triglyceride (TAG) synthesis but as well as functioning as a
secondary signaling molecule. DAG is shown to recruit certain protein kinases to the
plasma membranes where it leads to their activation (Newton, 2001). Some of these
proteins include Protein Kinase C µ/PKD as well as other PKC isoforms (Brose et al.,
2004; Eichmann & Lass, 2015; Q. J. Wang, 2006). With this in mind, we sought to
measure the protein expression of PKCµ and other PKC isoforms such as α and θ. It has
been shown that PKCµ is activated when it is phosphorylated at residues Serine 744 and
748. When we measured the phospho-PKCµ at these sites in TA and GAS in
Lipin1Myf5cKO mice, the results showed a decrease in their activation. A western blot
analysis showed that phopho-PKCµ at Serine 744 and 748 was reduced by about 70%
compared to the wild-type suggesting a decrease in the activation. PKCα phosphorylated
at Serine 657 was also reduced by 63% in both TA and GAS muscle of Lipin1Myf5cKO
mice. PKCθ, phosphorylated at Threonine 538 was reduced by about 40% in the TA
muscle (Figure 7). The total levels of PKC were not changed. This led us to conclude that
lipin1 deficiency leads to the reduction of PKC activation through DAG in the skeletal
muscles. As aforementioned, PKC activation leads to downstream signaling cascade that
are important for cellular differentiation and cell growth. This also makes PKC proteins
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important for myogenesis. So far we saw the reduction in myogenic factors and the
diminished activation of PKCs. This led us to further look into signaling mechanism and
relationship between PKC, MyoD and MEF2c. Brunelli et al (Brunelli, Relaix, Baesso,
Buckingham, & Cossu, 2007) has implicated PKCµ in MyoD expression but a detailed
mechanism of action is not well understood.
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Figure 7: Lipin1 deficiency diminishes PKC activation. A Representative immunoblots
(A) and densitometry graphs of lipin1 and different protein kinase expression and
phosphorylation in GAS (B) and TA (C) muscles in WT and Lipin1Myf5cKO mice at 3month-old.
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3. Lipin1 is required for myoblast differentiation in cell culture.
To explore the mechanism, we used C2C12 cells for in vitro studies where we
knockdown lipin1 and differentiate them to form myotubes, which eventually fuse
together and form myofibers. Our aim here was to clarify if lipin1is important for
myoblast differentiation. We knocked down lipin1 using adenovirus driven shRNA. The
cells were then differentiated for 6 days. Myotube formation was examined using Mf20
immunostaining to detect myosin heavy chain (MHC)-positive myotubes. We found that
lipin1 knockdown in C2C12 cells inhibited myoblast differentiation and impacted
myotube formation compared to the wild type or shLacZ treated cells (Figure 8A). The
shRNA treated C2C12 has a reduced fusion index compared to the wild type. Fusion
index is calculated as the percentage of nuclei contained in myosin-positive myotubes.
The index for the shRNA treated was reduced to 30% from 49% of that of the control
(Figure 8B). This experiment was consistent with the pervious work done by Jiang et al
(Jiang et al., 2015) that lipin1 is required for myoblast differentiation.
Molecularly, we wanted to see if the same proteins that are down regulated in the
tissue were also down regulated in these shRNA treated C2C12 cells. In this approach,
we knockdown lipin1 in C2C12 cells and differentiated them at different time points:
Day 0 (before differentiation), Day 3 (3 days post-differentiation) and Day 6 (6 days
post-differentiation). These cells were then harvested for protein analysis using western
blot. We analyzed the expression levels of myogenic factors and Protein Kinase C. First,
the expression levels of Myf5 were not altered, consistent with tissue data. Next, MyoD
and MEF2c were measured, which showed a dramatic reduction at Day 6 postdifferentiation. A reduction of 75% of MyoD compared to the wild type was observed.
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Lastly, PKCµ activation was analyzed by measuring phospo-PKCµ. Consistent with the
tissue data, PKCµ activation was reduced dramatically, a 60% reduction at Day 6
compared to the wild type (Figure 8C, D).
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Figure 8: Lipin1 is required for myoblast differentiation in cell culture.C2C12
myoblasts were infected with adenovirus to knockdown lipin1 (shLpin1) or control
shLacZ before differentiation. (A) Cells were fixed and stained for Mf20+ and DAPI
(Scale bars, 50µm). (B) Fusion index was determined by counting the percentage of
nuclei within Mf20+ myotubes over total nuclei within five randomly selected fields per
sample. Protein expression levels (C) and densitometric analysis of PKC (D), myogenic
differentiation markers and MEF2c in differentiated myoblasts. *p<0.05; **p<0.01.
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4. Inhibition of PKCµ activity suppresses myoblast differentiation through
inhibiting MyoD and MEF2c expression in vitro.
After establishing that lipin1 knockdown in C2C12 exhibited down-regulated
myogenic regulatory factors as well as diminished activation of PKCµ, we sought
whether diminishing PKCµ activity with an inhibitor would result in a reduction of
myogenesis and myogenic factors. In this approach, we used CID755673, a selective
inhibitor for PKCµ, to selectively inhibit PKCµ activity. C2C12 were differentiated at
Day 0, Day 4 and Day 6. The PKCµ inhibitor was added to the media before and after
differentiation. Cells were then harvested for immunostaining and protein expression
using western blot. Similar to lipin1 knockdown, when C2C12 cells were treated with
CID755673 inhibitor, the myotube formation and differentiation was reduced as
evidenced by the MHC-positive myotubes detected by Mf20 Immunostaining (Figure
9A). In addition, the fusion index was reduced from 50% to 31% for the CID755673
treated (Figure 9B). This confirms that PKCµ activation is important for myotube
formation and C2C12 differentiation. Next, we measured the protein expression of
phospho-PKCµ Ser744/748, MyoD and MEF2c. Their protein expression was also
reduced by 70%, 75% and 63%, respectively, at Day 6 (Figure 9C, D).
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Figure 9: Inhibition of PKCµ activity suppresses myoblast differentiation through
inhibiting MyoD and MEF2c expression in vitro.C2C12 myoblasts were treated with a
PKCµ inhibitor, CID 755673, for 6 days, and subjected to myoblast differentiation. 6
days after differentiation, (A) cells were fixed and stained with Mf20 and DAPI. (Scale
bars, 50µm) (B) Fusion index was calculated. (C) Cell lysate was harvested, and protein
expression was measured by western blot. (D) Protein expression levels in C were
quantified by densitometric analysis and normalized to β-actin. **p<0.01.
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5. Lipin1 deficiency decreases MEF2 and MyoD by inhibiting the nuclear
export of HDAC5.
The story has so far been that lipin1 deficiency leads to the inactivation of PKCµ
through the loss of DAG accumulation. However, how does the diminished activity of
PKCµ lead to decreased MyoD and MEF2c is not fully clear. It has been suggested that
MyoD and MEF2c interact with each other through its DNA binding and dimerization
motifs, which in turn activate myogenesis process (Black, Molkentin, & Olson, 1998;
Kaushal, Schneider, Nadal-Ginard, & Mahdavi, 1994; Molkentin et al., 1995). It has also
been shown that MEF2c proteins interact with Class II Histone Deacetylase 5, HDAC5.
This interaction is thought to result in the repression of MEF2c protein transcriptional
activity, which is important for myogenic gene expression (Bertos et al., 2001; Lu,
McKinsey, Nicol, et al., 2000). In addition, the signaling cascade chaperone proteins, the
14-3-3 binding proteins are thought to aid the interaction between MEF2c and HDAC5
through PKCµ and CaMK signaling cascades (Bertos et al., 2001; McKinsey, Zhang, &
Olson, 2000). For full cooperative activity of MEF2c and MyoD, the HDAC5 protein
must be dissociated from MEF2c and exported from the nucleus to the cytoplasm
(McKinsey, Zhang, Lu, et al., 2000; McKinsey, Zhang, & Olson, 2000). With this in
mind, we sought to measure HDAC5 activity through its phosphorylated form at Ser 259.
When HDAC5 is phosphorylated, it indicates that the signaling cascade through PKCµ is
active and that MEF2c repression is relieved. When we measured the protein expression
levels of phospho-HDAC5 in skeletal muscles of Lipin1Myf5cKO mice, we saw a
substantial reduction in its phosphorylation, indicating that the upstream signaling
cascade, PKCµ, is lost or reduced (Figure 10A). To further solidify what we are
observing in the tissue is consistent with cell culture, we measured the phospho-HDAC5
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in the differentiated C2C12 cells treated with CID755673, a PKCµ inhibitor. As shown in
Figure 10B, the phospho-HDAC5 is reduced in these differentiated cells at Day 6 treated
with the inhibitor. In both tissues and cells, the total HDAC5 protein levels were not
changed. These experiments suggest that PKCµ is important for translocating HDAC5
from the nucleus through phosphorylation, which leads to the transcriptional function of
MEF2c and MyoD to advance.
Next to delineate the subcellular localization of HDAC5 we found that, through
overexpression, HDAC5 is exclusively localized in the nucleus (Figure 10C). Since
HDAC5 is a transcription repressor protein, it always localizes in the nucleus. However,
when we co-overexpressed lipin1 with HDAC5, it induced the nuclear export of HDAC5.
To further clarify which activity of lipin1 was responsible for the HDAC5 nuclear export,
we co-overexpressed HDAC5 with lipin1 that was mutated in its catalytic activity site,
D712A. Interestingly, this did not induce HDAC5 nuclear export; further illustrating that
lipin1 catalytic activity is important for HDAC5 nuclear export and further transcriptional
de-repression of genes; in this case myogenic genes. Additionally, we co-overexpressed
HDAC5 with PKCµ, which also led to the nuclear export of HDAC5. To determine if
DAG is responsible for the PKCµ activation, we used Phorbol 12-myristate 13-acetate
(PMA), a DAG analogue. Cells were overexpressed with HDAC5 and then treated with
PMA for 30 minutes. HDAC5 subcellular localizations were then evaluated. We
observed that PMA treatment drove the subcellular localization of HDAC5 from the
nucleus to the cytoplasm, same as PKCµ and lipin1 co-overexpression (Figure 10D).
Throughout these experiment, we concluded that a signaling cascade exists in
lipin1, DAG, PKCµ and HDAC5. Consequently, we believe that the activation of PKCµ
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through lipin1/DAG and subsequent HDAC5 nuclear export that results in the
dissociation of MEF2c-HDAC5 complex, leads to the activation of MEF2c and myogenic
regulatory factors. Our overall conclusion is that lipin1 deficiency hinders skeletal muscle
differentiation by inhibiting MEF2 and MyoD through PKCα and PKCµ activity and that
it failed to induce HDAC5 nuclear export and release the inhibitory function of HDAC5
to MEF2c (Fig 10E).
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Figure 10: Lipin1 regulates HDAC5 nuclear export through activation of PKCµ. (A)
Western blot of HDAC5 and phosphorylated HDAC5 in the GAS and TA muscle of WT
and Lipin1Myf5cKO mice. (B) C2C12 myoblasts were treated with CID 755673 for 6 days,
and subjected to myoblast differentiation. 6 days after differentiation, cell lysate was
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harvested; the protein expression levels of HDAC5 and phosphorylated HDAC5 were
measured by western blot. (C) Cos7 cells were transfected with either GFP-tagged
HDAC5 or along with HA-tagged lipin1, catalytic mutant lipin1-D712A or HA-tagged
PKCµ. Cells were fixed 24 h after transfection, and subcellular localization of lipin1 and
HDAC5 were examined by anti-HA (red), anti-GFP (green) antibodies. Nuclei were
detected by DAPI (blue). Co-localization of HDAC5 and lipin or PKCµ were determined.
(D) Cos7 cells transfected with HDAC5 treated with/without PKC agonist, PMA, for
30min. Subcellular localization of HDAC5 was examined by immunostaining. (Scale
bars, 50µm) (E) Model of PKCµ regulation of HDAC5 subcellular localization.
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6. Lipin1 deficiency affects miR-1 expression and Pax7 transcriptional activity
in Lipin1Myf5cKO mice.
Pax7 is an important marker for satellite cells. The function of these cells is to
serve as myogenic stem cells that are readily available for differentiation after muscle
injury (Endo, 2015; Sambasivan & Tajbakhsh, 2015). Some studies have shown that
Pax7 acts upstream of other myogenic factors such as MyoD (Sambasivan & Tajbakhsh,
2015; von Maltzahn, Jones, Parks, & Rudnicki, 2013; Wood et al., 2013). Although there
was no change in the Myf5 gene and protein expressions in Lipin1Myf5cKO mice, we
observed an increase of Pax7 protein levels, up to two folds, in their skeletal muscles
(Figure 11A, B). In addition to protein, immunohistochemistry against pax7 was done.
The pax7 expressing satellite cells in the Lipin1Myf5cKO mice were increased two fold
compared to the wild type (Figure 11C, D). It has been reported that pax7 inhibits
satellite cells to differentiate and keeps satellite cells in their quiescent stage (von
Maltzahn et al., 2013). Liu et al (Liu et al., 2007) has reported that microRNAs (MiR)
play an important role in myogenesis where they are positively regulated by MEF2c
expression. These MiRs are thought to regulate differentiation process tightly. Another
study has proposed that pax7 is inhibited by these MiRs (J. F. Chen et al., 2010). Some of
these MiRs include miR-1. After observing the increase of pax7 protein levels in
Lipin1Myf5cKO mice, we wanted to see if the miR-1 was impacted. We measure the miR-1
levels and observed a decrease in Lipin1Myf5cKO mice compared to the wild type. This led
us to believe that the reduction of MEF2c contributed to the reduction in miR-1, a
negative regulator of pax7, thus increasing the pax7 levels (Figure 11E).
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Figure 11: Suppression of MEF2c and MyoD induces accumulation of Pax7. Western
blot (A) and densitometric analysis (B) of Pax7 expression in GAS muscle of 3-monthold WT and lipin1Myf5cKO mice. (C) Immunostaining of Pax7 (green) and laminin (red) on
transverse sections of GAS muscle of 3-month-old WT and lipin1Myf5cKO mice. Scale bar
= 100µm. (D) Quantification of the number of Pax7-positive cells divided by the total
number of nuclei in a given microscopic field. For each muscle section, at least 6
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different fields were quantified and averaged. Data are mean ± s.e.m. (E) RT-PCR
analysis of miR-1 expression in GAS of WT and Lipin1Myf5cKO mice. *p<0.05; **P<0.01.
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IV.

Discussion

Our study suggests that lipin1 plays an important role in skeletal muscles
development (Figure 12). We showed that lipin1 deficiency leads to the reduction of
skeletal muscle mass through the loss of PKCµ and PKCα signaling activity, which
regulates HDAC5-cytoplasmic and nuclear shuttling. When HDAC5 is phosphorylated at
Ser259 by PKCµ or PKCα, it is exported from the nucleus, releasing its inhibitory
function in myogenic genes such as MyoD and MEF2c; this in turn leads to the activation
of myoblast differentiation and skeletal muscle development.
Our in vitro experiments found that the absence of lipin1 in myoblasts leads to an
inhibition of myoblast differentiation. This reduction was due to the loss of PAP activity
of lipin1, which subsequently is needed for DAG and TAG synthesis. Our results also
suggested that PKCµ and PKCα were reduced in their activation through the loss of
phosphorylation. This led us to believe that PKC activation was important for myoblast
differentiation and becoming mature myotubes. We believe that the reduction in
activation of PKCµ and PKCα were due to the loss of the DAG. It has been shown that
DAG, a secondary signaling molecule, leads to the activation of protein kinases such as
PKCµ and PKCα isoforms (Q. J. Wang, 2006). A study by Kleger, et al (2011), have
showed that the depletion of PKCµ by shRNA in C2C12 myoblast led to the inhibition of
myoblast differentiation while an ectopic expression of PKCµ showed enhanced
myoblast differentiation (Kleger et al., 2011). In addition, we found that lipin1 deficiency
leads to the reduction of MyoD and MEF2c expression and that their decrease in
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expression is due to the upstream loss of PKCµ activation. We believe that myoblast
differentiation is regulated by PKCµ activity through the activation of myogenic factors;
MyoD and MEF2c by showing that PKCµ inhibition resulted in stunted myoblast
differentiation and reduction in MyoD and MEF2c.
The cooperative activity between MyoD and MEF2c transcription factors are
thought to promote the expression of myogenic factors that are needed to shift myoblasts
from an undifferentiated myoblasts to differentiated myoblasts that become myotubes
(Lu, McKinsey, Zhang, et al., 2000). Our study suggests that lipin1 deficiency leads to
the reduction of MyoD and MEF2c expression in both in vivo and in vitro and that their
expressions are dependent on each other. Previous studies have suggested that MyoD and
MEF2c interact with each other during myogenesis through their DNA binding domains
(Potthoff & Olson, 2007; Tapscott, 2005). Since MyoD and MEF2c are transcription
factors, it is possible that they both positively regulate each other’s expression. For
clarification on their impact on each other, further studies need to be carried on their role
in myogenesis.
In our study, we showed that lipin1 regulates MyoD and MEF2c expression
through relieve of HDAC5 suppression from the nucleus and export to the cytoplasm. We
showed that lipin1 catalytic activity is important in this myoblast differentiation and
skeletal muscle development. Here, lipin1 activity leads to the phosphorylation of
HDAC5 and resulting in its trafficking from the nucleus to the cytoplasm. For further
confirmation if the catalytic activity of lipin1 is the ultimate regulator of HDAC5
nucleocytoplasmic trafficking, we deployed lipin1 inactive mutant for catalytic activity,
D712A. It showed that lipin1 mutant did not lead to the nuclear export of HDAC5,
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meaning that the catalytic activity of lipin1 is required for the HDAC5 nucleocytoplasmic
trafficking. Furthermore, when we co-overexpressed PKCµ and HDAC5, instead of
HDAC5 only, we observed that HDAC5 nuclear export in PKCµ co-overexpression
compared to the HDAC5 alone. Our study also showed that treatment of PMA, a DAG
agonist, led to the nuclear export of HDAC5, showing that DAG secondary signaling
activity is responsible for the HDAC5 trafficking.
In our findings, we propose that lipin1 regulates the transcription de-repression of
myogenic factors by regulating HDAC5 nucleocytoplasmic trafficking through
DAG/PKC pathway. In early-undifferentiated myoblasts, HDAC5 is bound to MEF2c
through the HDAC-interacting domain to repress the MEF2c activity to block myoblast
differentiation. During myoblast differentiation and skeletal muscle development, MEF2c
is relieved from repression by signaling cascade that leads to the phosphorylation of
HDAC5 and its translocation to the cytoplasm, thus allowing the MEF2c to be activated.
In addition to the reduced expression of myogenic factors such as MyoD and
MEF2c, we observed an increase of Pax7 expression in Lipin1Myf5cKO mice at the protein
level. This increase of Pax7 due to lipin1 deficiency leads us to conclude that the
reduction of MyoD and MEF2c factors play a role. Pax7 expression is induced in satellite
cells and this observed increase of Pax7 is propelling these cells for self-renewal instead
of progressing to the next stage of becoming myoblasts and eventual myogenic
differentiation. Some studies suggest that myogenic factors such as MyoD regulate the
expression of Pax7 (Sincennes et al., 2016; Wood et al., 2013). This phenotype is
consistent with a previous study (P. Zhang, Verity, & Reue, 2014) in that lipin1 deficient
fld mice showed necrosis as well as persistent muscle fiber regeneration.
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In summary, our study has identified that lipin1 plays an important role in
regulating skeletal muscle development through the activation of PKCµ and PKCα
isoforms that leads to the signaling cascade that activates the myogenic factors that are
essential for myogenesis by relieving the repressive activity of HDAC5.
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Figure 12: Lipin1 is critical for embryonic SM differentiation.
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